Alvaro
Lassaletta Atienza
Consultor Médico
Institute Catalá Oncología
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Institute Catalá Oncología (4)
2020
-
First-in-Human, First-in-Child Trial of Autologous MSCs Carrying the Oncolytic Virus Icovir-5 in Patients with Advanced Tumors
Molecular Therapy, Vol. 28, Núm. 4, pp. 1033-1042
-
Genetic and immune changes associated with disease progression under the pressure of oncolytic therapy in a neuroblastoma outlier patient
Cancers, Vol. 12, Núm. 5
2016
-
Influence of carrier cells on the clinical outcome of children with neuroblastoma treated with high dose of oncolytic adenovirus delivered in mesenchymal stem cells
Cancer Letters, Vol. 371, Núm. 2, pp. 161-170
2010
-
Treatment of metastatic neuroblastoma with systemic oncolytic virotherapy delivered by autologous mesenchymal stem cells: An exploratory study
Cancer Gene Therapy, Vol. 17, Núm. 7, pp. 476-483